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Abstract
Introduction: Intensive care may prolong the dying process in patients who have been unresponsive to the
treatment already provided. Limitation of life-sustaining therapy, by either withholding or withdrawing support, is
an ethically acceptable and common worldwide practice. The purpose of the present study was to examine the
frequency, types, and rationale of limiting life support in Greek intensive care units (ICUs), the clinical and
demographic parameters associated with it, and the participation of relatives in decision making.
Methods: This was a prospective observational study conducted in eight Greek multidisciplinary ICUs. We studied all
consecutive ICU patients who died, excluding those who stayed in the ICU less than 48 hours or were brain dead.
Results: Three hundred six patients composed the study population, with a mean age of 64 years and a mean
APACHE II score on admission of 21. Of study patients, 41% received full support, including unsuccessful
cardiopulmonary resuscitation (CPR); 48% died after withholding of CPR; 8%, after withholding of other treatment
modalities besides CPR; and 3%, after withdrawal of treatment. Patients in whom therapy was limited had a longer
ICU (P < 0.01) and hospital (P = 0.01) length of stay, a lower Glasgow Coma Scale score (GCS) on admission (P <
0.01), a higher APACHE II score 24 hours before death (P < 0.01), and were more likely to be admitted with a
neurologic diagnosis (P < 0.01). Patients who received full support were more likely to be admitted with either a
cardiovascular (P = 0.02) or trauma diagnosis (P = 0.05) and to be surgical rather than medical (P = 0.05). The main
factors that influenced the physician’s decision were, when providing full support, reversibility of illness and
prognostic uncertainty, whereas, when limiting therapy, unresponsiveness to treatment already offered, prognosis
of underlying chronic disease, and prognosis of acute disorder. Relatives’ participation in decision making occurred
in 20% of cases and was more frequent when a decision to provide full support was made (P < 0.01). Advance
directives were rare (1%).
Conclusions: Limitation of life-sustaining treatment is a common phenomenon in the Greek ICUs studied. However,
in a large majority of cases, it is equivalent to the withholding of CPR alone. Withholding of other therapies besides
CPR and withdrawal of support are infrequent. Medical paternalism predominates in decision making.
Introduction
Intensive care may prolong the dying process in patients
who have been unresponsive to the treatment already
provided and for whom the possibility of surviving or
regaining an acceptable quality of life is nil. Withholding
and withdrawal of life-sustaining treatment were
introduced to avoid the futile suffering of dying patients.
These practices are based on the principles of bioethics;
they are common worldwide, have been approved by the
international scientific community, and must not be
confused with euthanasia [1,2].
Observational studies conducted in several countries
on different continents showed that a large proportion of
i n t e n s i v ec a r eu n i t( I C U )d e a t h sa r ep r e c e d e db yw i t h -
holding or withdrawal of treatment, and that a variety of
clinical parameters are associated with the decision to
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withdrawal of treatment and the degree of involvement
of relatives in the decision making are influenced by the
cultural context [13,14].
The objective of this multicenter study was to study
the frequency, types, and rationale for limiting life sup-
port in Greek multidisciplinary ICUs, the clinical and
demographic parameters associated with it, and the par-
ticipation of relatives in the decision-making process.
Materials and methods
This was a prospective observational study conducted in
eight multidisciplinary, general hospital-affiliated ICUs
(seven in Athens, and one in Nicosia, Cyprus). The con-
tribution of each ICU and the dates defining the periods
of data collection are presented in Table 1. In terms of
the number of beds, the participating ICUs represent
about one third of the total in Greece and Cyprus. We
studied all consecutive ICU patients who died, excluding
those who stayed in the ICU less than 48 hours or were
diagnosed with brain death.
The physician in charge of each study patient was invited
1. To classify the patient into one of four mutually
exclusive categories: patients who received full support,
including unsuccessful cardiopulmonary resuscitation
(CPR) (group A); those who received active support up
to but not including CPR (group B); those with a deci-
sion to withhold (not to start/escalate) some form of
life support besides CPR (group C); or those with a
decision to withdraw an existing form of life support
(group D).
2. To complete an anonymous questionnaire, indicat-
ing the factors that influenced his or her decision to
offer full support or to limit therapy (choosing them
from among a list of prespecified items and weighing
them on a scale ranging from 0 for no impact to 4 for
ultimate impact), the degree and nature of relatives’
involvement in the decision-making process, the reasons
for not discussing end-of-life dilemmas with the patient
and family, whether a consensus was reached in the
medical team about the decision, and whether advance
directives existed. In addition, if a decision to limit
therapy was taken, the physician was asked to note the
life-support modalities withheld or withdrawn. The phy-
sicians of each ICU deposited the completed question-
naire in a sealed unmarked box. The several boxes
collected from participating ICUs were mixed and
opened all together at the end of the study.
For all patients, the following clinical and demographic
data were extracted from the charts: age, gender, hospital
and ICU length of stay, origin of admission (emergency
department, medical ward, surgical ward, operating
room, other ICU), admission diagnosis, chronic disorders
(malignancy, acquired immunodeficiency syndrome
(AIDS)/human immunodeficiency virus (HIV), cirrhosis,
chronic heart failure of New York Heart Association
(NYHA) classes III to IV, chronic respiratory insuffi-
ciency, chronic renal disease requiring dialysis, chronic
neurologic or psychiatric disease), surgical status, Glas-
gow Coma Scale score (GCS) and Acute Physiology and
Chronic Health Evaluation (APACHE) II scores on
admission to the ICU, and APACHE II 24 hours before
death.
Statistical analysis was performed to determine differ-
ences between the group of patients who received full
support including unsuccessful CPR (group A), and the
group of patients in whom therapy was limited in any
way (including withholding of CPR, withholding of
some form of life support besides CPR, and withdrawal
of treatment (groups B, C, and D, consolidated)). Cate-
goric variables were analyzed with the c
2 test, and con-
tinuous variables with the t test. Differences were
accepted as statistically significant when P <0 . 0 5 .A l l
statistical tests were two-tailed.
The study protocol was approved by the Scientific
Council and the Ethics Committee of Evangelismos
Hospital, Athens, Greece. Informed consent was not
required, because no interventions or treatments were
given to the patients as part of this observational study,
Table 1 Periods of data collection and contributions of individual ICUs
ICU Period of data collection Patients admitted Patients included in the study
1 27/11/06 to 26/11/07 and 1/10/08 to 31/5/09 763 159
2 1/1/08 to 15/11/08 137 28
3 15/9/08 to 10/12/08 66 14
4 10/9/08 to 31/5/09 312 26
5 19/1/09 to 22/9/09 115 25
6 1/10/08 to 31/8/09 92 15
7 1/8/09 to 31/10/09 114 8
8 1/3/09 to 31/8/09 441 31
Total 2,040 306
ICU, intensive care unit.
Kranidiotis et al. Critical Care 2010, 14:R228
http://ccforum.com/content/14/6/R228
Page 2 of 9and the process of the study did not affect therapeutic
decisions.
Results
During the study, 2,040 patients (range, 66 to 763
patients per center) were admitted to the ICUs over a 9-
month period (range, 3 to 20 months). Of the 2,040
patients, 464 (23%) died. Of the 464 patients, 132 were
excluded, 48 because they were diagnosed with brain
death, and 84 because they stayed in the ICU less than
48 hours. For 26 patients, information about the manner
of dying was unavailable. Thus, 306 patients composed
the study population. Their mean age was 64 ± 17 (SD)
years, and their mean APACHE II score on admission
to the ICU was 21 ± 7 (SD).
One hundred twenty-four (41%) patients received full
support, including unsuccessful CPR. Limitation of life-
sustaining therapy occurred in 182 (59%) patients: 148
(48%) died after withholding of CPR, 25 (8%), after with-
holding of other treatment modalities besides CPR, and
nine (3%) after withdrawal of treatment.
Table 2 lists the demographic and clinical characteris-
tics of patients according to whether therapy was limited.
Patients in whom therapy was limited had a statistically
significantly longer hospital and ICU stay, a lower
admission GCS score, a higher APACHE II score 24
hours before death, and were more likely to be admitted
with a neurologic diagnosis. Patients who received full
s u p p o r tw e r em o r el i k e l yt ob ea d m i t t e dw i t he i t h e ra
cardiovascular or a trauma diagnosis, and to be surgical
rather than medical.
The main factors influencing the physician’sd e c i s i o n
either to provide full support including CPR to patients
of group A, or to use every available life-sustaining
modality except CPR in patients of group B, were rever-
sibility of illness and prognostic uncertainty; the physi-
cian’s religious beliefs and legal concerns had minimal
impact (Tables 3 and 4). Correspondingly, the most
important factors affecting the decision either not to
resuscitate patients of group B, or to withhold or with-
draw life-sustaining treatment in patients of groups C
and D, were unresponsiveness to treatment already
offered, prognosis of underlying chronic disease, prog-
nosis of acute illness, and future poor health; age was
infrequently cited, whereas economic cost and lack of
ICU beds played almost no role (Tables 5 and 6).
Only three (1%) patients were involved in end-of-life
decisions; in two of these three cases, the patient
expressed a request for limitation of life-sustaining treat-
ment, which was ignored by the physician; in one case,
Table 2 Patient characteristics according to whether therapy was limited or not (n = 306)
Patient characteristics No limitation (n = 124) Any limitation (n = 182) P
Age, years
a 64 ± 17 65 ± 17 0.75
Male gender, n (%) 76 (61) 112 (62) 0.96
Hospital length of stay, days
b 22 (9 to 36) 27 (13 to 44) 0.01
ICU length of stay, days
b 10 (5 to 19) 15 (7 to 31) <0.01
APACHE II on admission to the ICU
a 20 ± 8 21 ± 7 0.22
GCS on admission to the ICU
b 14 (8 to 15) 10 (6 to 15) <0.01
APACHE II 24 hours before death
a 23 ± 7 27 ± 7 <0.01
Having one or more chronic disorders,
c n (%) 64 (55) 114 (64) 0.12
Having malignancy, n (%) 29 (25) 48 (27) 0.72
Admission diagnosis, n (%)
Cardiovascular 28 (23) 23 (13) 0.02
Respiratory 29 (24) 53 (29) 0.30
Gastrointestinal 21 (17) 31 (17) 0.97
Neurologic 9 (7) 40 (22) <0.01
Sepsis 5 (4) 7 (4) 0.91
Trauma 17 (14) 13 (7) 0.05
Surgical, n (%) 68 (55) 79 (44) 0.05
Origin of admission, n (%)
Emergency room 15 (13) 29 (16) 0.34
Medical ward 42 (35) 59 (33) 0.68
Surgical ward 37 (31) 53 (30) 0.78
Operating room 18 (15) 26 (14) 0.78
ICU of other hospital 7 (6) 12 (7) 0.78
aMean ± SD.
bMedian, quartiles.
cMalignancy, AIDS/HIV, cirrhosis, chronic heart failure NYHA III to IV, chronic respiratory insufficiency, chronic renal disease
requiring dialysis, chronic neurologic or psychiatric disease. AIDS, acquired immunodeficiency syndrome; APACHE, Acute Physiology and Chronic Health
Evaluation; GCS, Glascow Coma Scale; HIV, human immunodeficiency virus; ICU, intensive care unit; NYHA, New York Heart Association; SD, standard deviation.
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Of the patients, 89% were mentally incompetent at the
time of the decision; 5% were unaware of their diagnosis
or prognosis or both; and 3% were judged to be unable
to comprehend the dilemma posed. Advance directives
were rare (1%).
Relatives’ participation in decision making occurred in
20% of cases and was more frequent when a decision to
offer full support was madet h a nw h e nt r e a t m e n tw a s
limited in any way (P < 0.01) (Table 7). Conversations
were principally initiated by the physician (62%). Rea-
sons for not discussing end-of-life practices with rela-
t i v e sw e r ea sf o l l o w s :t h ef a m i l yw a st h o u g h tn o tt o
understand (60%); the family was unavailable (25%);
such a discussion was considered unnecessary by the
physician (10%); or the family did not want to partici-
pate in the decisions (4%).
In 94% of cases, the medical team reached consensus
about the end-of-life practice followed. Nurses were
never included in consensus development, but were
informed about the decisions. Almost always (98%), the
attending physician stated that he or she was sure that
he or she had made the right decision. Only 6% of
patients in whom CPR was withheld had a written
account of the “do not resuscitate” (DNR) decision pre-
sent in their charts. However, decisions to forego (with-
hold or withdraw) life-sustaining therapy (besides CPR)
were documented in the medical record in 52% of the
corresponding cases.
The therapeutic interventions most frequently with-
held/withdrawn were vasopressors/inotropes and dialy-
sis. Other life-support modalities withheld/withdrawn
are shown in Table 8. The median time from ICU
admission to the decision to withhold treatment was
Table 3 Factors that influenced the decision to provide full support, including unsuccessful CPR, ranked by impact
Factor Impact on the decision
No Little Moderate Much Ultimate
Reversibility of illness 8 (8) 6 (6) 14 (14) 16 (16) 54 (55)
Prognostic uncertainty 23 (23) 7 (7) 13 (13) 30 (31) 25 (26)
Age (years) 43 (44) 18 (18) 10 (10) 5 (5) 22 (22)
Relatives’ opinion 45 (46) 13 (13) 12 (12) 8 (8) 20 (20)
Emotion/conscience 51 (52) 5 (5) 15 (15) 19 (19) 8 (8)
Physician’s religious beliefs 65 (66) 6 (6) 10 (10) 15 (15) 2 (2)
Legal concerns 74 (76) 13 (13) 7 (7) 1 (1) 3 (3)
Patient’s will 74 (76) 8 (8) 5 (5) 6 (6) 5 (5)
Bad communication with relatives 87 (89) 6 (6) 2 (2) 2 (2) 1 (1)
Family pressures 90 (92) 3 (3) 0 (0) 2 (2) 3 (3)
Disagreements within the medical team 90 (92) 5 (5) 0 (0) 0 (0) 3 (3)
Disagreements within the family 93 (95) 4 (4) 0 (0) 0 (0) 1 (1)
Data are presented as numbers (percentages) of patients. The respective section of the questionnaire was filled for 98 patients. CPR, cardiopulmonary
resuscitation.
Table 4 Factors that influenced the decision to provide active support up to but not including CPR, ranked by impact
Factor Impact on the decision
No Little Moderate Much Ultimate
Reversibility of illness 22 (16) 8 (6) 31 (22) 35 (25) 45 (32)
Prognostic uncertainty 46 (33) 16 (11) 33 (23) 29 (21) 17 (12)
Age (years) 81 (57) 18 (13) 13 (9) 11 (8) 18 (13)
Relatives’ opinion 79 (56) 15 (11) 14 (10) 13 (9) 20 (14)
Emotion/conscience 85 (60) 12 (9) 16 (11) 16 (11) 12 (9)
Physician’s religious beliefs 103 (73) 14 (10) 12 (9) 7 (5) 5 (4)
Legal concerns 118 (84) 13 (9) 4 (3) 4 (3) 2 (1)
Patient’s will 125 (89) 8 (6) 4 (3) 3 (2) 1 (1)
Bad communication with relatives 129 (91) 7 (5) 2 (1) 1 (1) 2 (1)
Family pressures 125 (89) 9 (6) 4 (3) 2 (1) 1 (1)
Disagreements within the medical team 130 (92) 6 (4) 3 (2) 0 (0) 2 (1)
Disagreements within the family 134 (95) 4 (3) 1 (1) 1 (1) 1 (1)
Data are presented as numbers (percentages) of patients. The respective section of the questionnaire was filled for 141 patients. CPR, cardiopulmonary
resuscitation.
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withholding of therapy to death was 48 hours (range,
0.5 hours to 30 days). The median time from ICU
admission to the decision to withdraw treatment was
14 days (range, 3 to 116 days). The median time from
withdrawal of therapy to death was 32 hours (range,
1 hour to 4 days). The withholding or withdrawal deci-
sion was considered by physicians to have been timely
in 79% of cases and inappropriately delayed in 21%.
Discussion
The present multicenter study demonstrates that limita-
tion of life-sustaining treatment is a common phenom-
enon in Greek ICUs; more than half of deaths are
preceded by a decision to forego some form of suppor-
tive therapy. Nevertheless, in the vast majority of cases
(>80%), the only limitation of treatment that takes place
is withholding of CPR. Withholding of other life-support
modalities besides CPR is not a routine practice,
whereas withdrawal of treatment is quite infrequent.
The observed rate of CPR use (40.5%) is consistent with
data reported from southern countries (Greece, Israel,
Italy, Portugal, Spain, and Turkey) in the European Ethi-
cus study, and is much higher than the European mean
(21%) [3]. In northern European countries, as well as in
North America, the incidence of withholding and with-
drawal of life-sustaining treatment reaches 90% of
patients who die in the ICU [3,15].
Table 5 Factors that influenced the decision to withhold CPR, ranked by impact
Factor Impact on the decision
No Little Moderate Much Ultimate
Unresponsiveness to treatment already offered 33 (23) 0 (0) 7 (5) 11 (8) 90 (64)
Prognosis of underlying chronic disease 17 (12) 3 (2) 6 (4) 29 (21) 86 (61)
Prognosis of acute illness 33 (23) 8 (6) 17 (12) 24 (17) 59 (42)
Future poor health 67 (48) 8 (6) 14 (10) 17 (12) 35 (25)
Preexisting poor health 74 (52) 12 (9) 11 (8) 17 (12) 27 (19)
Age (years) 96 (68) 14 (10) 7 (5) 6 (4) 18 (13)
Aggressiveness of treatment, discomfort disproportionate to expected benefit 95 (67) 19 (13) 5 (4) 10 (7) 12 (9)
Physical and psychological pain 81 (57) 17 (12) 14 (10) 16 (11) 13 (9)
Emotion/conscience 108 (77) 14 (10) 12 (9) 0 (0) 7 (5)
Relatives’ opinion 120 (85) 9 (6) 6 (4) 2 (1) 4 (3)
Physician’s religious beliefs 118 (84) 9 (6) 10 (7) 4 (3) 0 (0)
Economic cost 129 (91) 7 (5) 4 (3) 0 (0) 1 (1)
Patient’s will 134 (95) 3 (2) 4 (3) 0 (0) 0 (0)
Lack of ICU beds 134 (95) 5 (4) 1 (1) 0 (0) 1 (1)
Data are presented as numbers (percentages) of patients. The respective section of the questionnaire was filled for 141 patients. CPR, cardiopulmonary
resuscitation; ICU, intensive care unit.
Table 6 Factors that influenced the decision to withhold or withdraw treatment, ranked by impact
Factor Impact on the decision
No Little Moderate Much Ultimate
Unresponsiveness to treatment already offered 2 (6) 0 (0) 3 (9) 4 (12) 24 (73)
Prognosis of underlying chronic disease 4 (12) 1 (3) 0 (0) 3 (9) 25 (76)
Prognosis of acute illness 2 (6) 1 (3) 3 (9) 7 (21) 20 (61)
Future poor health 8 (24) 0 (0) 1 (3) 6 (18) 18 (55)
Preexisting poor health 13 (39) 3 (9) 1 (3) 4 (12) 12 (36)
Aggressiveness of treatment, discomfort disproportionate to expected benefit 7 (21) 4 (12) 6 (18) 2 (6) 14 (42)
Physical and psychological pain 9 (27) 10 (30) 3 (9) 9 (27) 2 (6)
Age (years) 18 (55) 5 (15) 4 (12) 4 (12) 2 (6)
Emotion/conscience 19 (58) 7 (21) 3 (9) 3 (9) 1 (3)
Relatives’ opinion 20 (61) 4 (12) 5 (15) 1 (3) 3 (9)
Physician’s religious beliefs 25 (76) 3 (9) 3 (9) 2 (6) 0 (0)
Economic cost 31 (94) 1 (3) 1 (3) 0 (0) 0 (0)
Patient’s will 32 (97) 0 (0) 0 (0) 0 (0) 1 (3)
Lack of ICU beds 33 (100) 0 (0) 0 (0) 0 (0) 0 (0)
Data are presented as numbers (percentages) of patients. The respective section of the questionnaire was filled for 33 patients. ICU, intensive care unit.
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withdrawal of mechanical ventilation happens only on
rare occasions. Although the same moral justification is
required to withdraw one form of support or another
[16], withdrawal of mechanical ventilation seems to be a
taboo practice. Clearly, given that patients usually die
soon after ventilator withdrawal, most Greek physicians
see ventilator support as the ultimate tool in life support,
which cannot be withdrawn without taking personal
responsibility for the death of a patient.
International discrepancies in end-of-life practices
have been considered to reflect cultural and religious
differences [13,14,17]. However, our study indicated that
religious faith did not exercise any noteworthy influence
on physician attitudes. Perhaps religion affects physician
attitudes in a less-obvious way, by being a part of the
culture in which the physicians have grown up. Addi-
tional explanations that have been proposed for the
lower frequency of limitation of treatment in southern
countries comprise the ambiguous legal context, and the
absence of guidelines from national scientific societies
[1,10,18-20]. Still, we found that physician reluctance to
withhold or withdraw treatment did not emanate from
legal concerns. It seems that, in southern Europe as well
as in the Middle and Far East, the traditional belief that
life must be preserved at all costs is stronger than that
in northern Europe and North America [11,19-21].
Despite the financial problems with which the Greek
health-care system is confronted, economic cost was not
proved to be a determinant of end-of-life decisions.
Similarly, notwithstanding the scarcity of ICU beds, in
almost no case was life support withheld or withdrawn
on the basis of resource allocation.
In this study, the choice between providing full sup-
port and foregoing life-sustaining therapy was driven
primarily by an evaluation of objective medical data,
mainly the predicted reversibility of the underlying and
acute conditions and the unresponsiveness to treatment
already offered. Prognostic uncertainty contributed con-
siderably to the decision not to withhold or withdraw
life-preserving interventions, indicating physician perse-
verence until all hope of patient survival had vanished.
When deciding to withhold or withdraw life-sustaining
therapy (besides CPR), physicians seriously took into
account the patient’s preexisting and future poor health.
Hence, physicians’ perception of patients’ quality of life
seems to be a substantial factor in such decisions.
In contrast to previous research [3,5,6,8,9,12,22], we
found no association between the limitation of treat-
ment and the patient’s age. Moreover, age was rarely
cited as a factor prompting the decision to forego life
support. This is an encouraging finding. It has been
argued that old age alone is not a valid justification for
refusing intensive care [23]. After all, the literature pro-
vides contradictory results as to whether the ICU mor-
tality of elderly patients is significantly higher than that
of young patients after adjustment for confounding fac-
tors [24-26].
Again, unlike in other studies [3,5,8,9,12,22,27],
patients who received full treatment and those who
underwent limitation of life-sustaining therapy did not
differ in regard to the severity of illness on admission to
the ICU (as measured by the APACHE II score) and the
presence of comorbidities, including malignancy. Con-
versely, patients in whom treatment was withheld/with-
drawn had a more protracted course, as reflected in
t h e i rl o n g e rh o s p i t a la n dI C Us t a y ,a n dah i g h e r
APACHE II score 24 hours before death. These findings
imply that, for each patient, end-of-life practice was not
determined by the initial clinical parameters, but it was
Table 7 Participation of patient and relatives in the decision-making process by end-of-life category
A( n = 98)
a B( n = 140)
a C( n = 23)
a D( n =8 )
a Total (n = 269)
a
No patient or family involvement 68 (69) 129 (92) 10 (43) 5 (63) 212 (79)
Patient consented 1 (1) 0 (0) 0 (0) 0 (0) 1 (0.4)
Patient disagreed 1 (1) 0 (0) 0 (0) 0 (0) 1 (0.4)
Relatives consented 26 (27) 10 (7) 13 (57) 3 (37) 52 (19)
Relatives disagreed 0 (0) 1 (1) 0 (0) 0 (0) 1 (0.4)
Patient disagreed, but relatives consented 1 (1) 0 (0) 0 (0) 0 (0) 1 (0.4)
Relatives insisted despite physician’ s recommendation to the contrary 1 (1) 0 (0) 0 (0) 0 (0) 1 (0.4)
Data are presented as numbers (percentages) of patients.
aNumber of patients for whom the respective section of the questionnaire was filled.
A, full support including unsuccessful CPR; B, active support up to but not including CPR; C, withholding (not starting or escalating) some form of life support
(besides CPR); D, withdrawal of existing treatment. CPR, cardiopulmonary resuscitation.
Table 8 Life-support modalities withheld/withdrawn
Modality Withholding (n = 25) Withdrawal (n =8 )
Vasopressors/inotropes 19 (76) 5 (63)
Dialysis 10 (40) 2 (25)
Transfusions 5 (20) -
Antibiotics 4 (16) 2 (25)
Mechanical ventilation 4 (16) 3 (37)
Parenteral nutrition 2 (13) 1 (13)
Data are given as numbers (percentages) of patients. Patients may have
several life-support modalities withheld or withdrawn. The respective section
of the questionnaire was filled for 33 patients.
Kranidiotis et al. Critical Care 2010, 14:R228
http://ccforum.com/content/14/6/R228
Page 6 of 9gradually shaped on the basis of the disorder’s unfavor-
able evolution, the development of an irreversible
sequence of complications, and the progressive physiolo-
gical deterioration.
Specific diagnostic categories (cardiovascular disease
and trauma) were correlated with fewer limitation deci-
sions. Furthermore, surgical patients were fully sup-
ported more often than were medical patients. On the
contrary, patients admitted with a neurologic diagnosis
were more likely to undergo limitation of treatment.
These findings have two possible explanations. First,
cardiovascular disease is deemed more reversible than is
neurologic injury, which is viewed as a devastating irre-
mediable damage. Second, in trauma as well as in many
surgical patients, illness is sudden and unexpected,
which may delay the recognition of futility and impede
decision making.
We observed that death does not always ensue shortly
after withholding or withdrawal of therapy; time from
withholding of therapy to death may be as long as 1
month. This observation suggests the need for transfer-
ing patients whose death is not immediately imminent
after limitation of treatment, to a suitable hospice, to
administer appropriate palliative care.
Our data indicate that paternalism prevails in the
Greek ICUs studied. The physician possesses a domi-
nant role in the decision-making process and retains the
final responsibility for end-of-life practice. Relatives’
involvement in decision making is uncommon, and
advance directives are rare. Respect for and confidence
in medical authority are deep-rooted in Greek culture.
Patients and families traditionally tend to entrust thera-
peutic decisions to physicians. In the same manner,
end-of-life decisions are envisaged as purely clinical or
professional judgments and are left to the doctor.
Besides, most patients with chronic terminal illnesses do
not have full knowledge of their diagnosis or prognosis.
Nondisclosure is believed to protect patients from anxi-
ety and depression, and to keep hope alive. Last, as has
emerged from several studies, in southern European
countries, the ethical principle of beneficence still over-
shadows autonomy [6,18,28-30].
The percentages of medical-record documentation of
limitation decisions were low, a finding that confirms the
results of the Ethicus study, which revealed a south-to-
north difference regarding the presence of written
accounts of such decisions [31]. Ideally, each patient’s
chart should have a complete documentation of the end-
of-life practice. However, physicians may not believe this
is necessary.
The strengths of the present study are the direct report-
ing of physicians’ actions rather than theoretic responses
to a survey’s questionnaire, the prospective design, the
enrollment of a sufficient number of consecutive patients
from multiple centers, the anonymity, and the fact that
data were collected not only about patients who died after
limitation of life-support but also about patients who died
despite ongoing active treatment. Exclusion of patients
who died within 48 hours after admission to the ICU is a
limitation of our study. We thought that, in this group of
patients, dealing with end-of-life dilemmas is unusual,
because, in most cases, important aspects of the previous
medical history are unknown, and prognosis is uncertain.
Another limitation is that the validity of the question-
naire may be challenged, because it was not tested
before the study. The questionnaire’s structure was
based on a literature survey of factors that influence
end-of-life practice. Also, we did not evaluate the impact
of patient race, ethnicity, religion, and socioeconomic
status on end-of-life decisions. Yet, a large variation of
these parameters does not exist in the Greek ICU
population.
Finally, we did not investigate the possible association
between physician characteristics (age, medical specialty,
years of clinical experience) and his or her willingness
to withhold or to withdraw life-sustaining therapies.
Conclusions
This prospective multicenter study showed that limita-
tion of life-sustaining treatment is a common phenom-
enon in the Greek ICUs studied. However, in a large
majority of cases, it is equivalent to the withholding of
CPR alone. Withholding of other therapies besides
CPR is not routine, and withdrawal of support is infre-
quent. The main factor guiding the decision to limit
therapy is unresponsiveness to treatment already
offered. Economic cost and lack of ICU beds seem to
play no role. As in other European countries, the
paternalistic model predominates in decision making.
By recording current medical practice and its motiva-
tions in end-of-life situations, our study helps to trans-
late moral principles into legal and scientific
guidelines. Such guidelines can use recent international
recommendations as a baseline reference and adapt
them to our local particularities.
Key messages
￿ Limitation of life-sustaining treatment is a com-
mon phenomenon in the Greek ICUs studied. How-
ever, in most cases, it involves the withholding of
CPR only.
￿ Withholding of other therapies besides CPR and
withdrawal of support are infrequent.
￿ Unresponsiveness to treatment already offered is
the main factor influencing the physician’s decision
to limit therapy.
￿ Medical paternalism prevails in the decision-making
process.
Kranidiotis et al. Critical Care 2010, 14:R228
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Page 7 of 9￿ Death does not always ensue shortly after with-
holding or withdrawal of treatment; patients whose
death is not immediately imminent should be trans-
ferred to suitable hospices.
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